Green Cross Health (GXH) H1 2026 earnings summary

Executive summary

• Operating revenue for the six months ended 30 September 2025 was $264.4m, up from $259.9m year-over-year.

• Net profit after tax increased to $9.1m from $8.1m in the prior year period.

• Basic earnings per share rose to 5.00 cents from 3.93 cents year-over-year.

Financial highlights

• Operating profit before interest and tax was $17.5m, up from $16.1m year-over-year.

• Total comprehensive income attributable to shareholders was $7.2m, with $1.9m to non-controlling interests.

• Cash and cash equivalents at period end were $23.7m, down from $28.9m a year earlier.

• Net cash inflow from operating activities was $21.6m, compared to $25.3m in the prior year.

Outlook and guidance

• An interim dividend of 3.00 cents per share was declared, fully imputed, to be paid in December 2025.